Potent anti-obesity effect of enteric-coated lactoferrin: reduction in visceral fat in Japanese adults with abdominal obesitySummary: This study evaluates the efficacy of enteric-coated lactoferrin (eLF) in reducing visceral fat in Japanese men and women with abdominal obesity. Over 8 weeks, participants taking 300 mg/day of eLF saw significant decreases in visceral fat area, body weight, BMI, and hip circumference compared to placebo. eLF shows promise in managing visceral fat accumulation without adverse effects, offering a potential natural supplement for obesity-related metabolic conditions.
Reference: T Ono, M Murakoshi, et al. - British Journal of Nutrition, 2010.
Link:Read the full study.

It exhibits strong antibacterial, antiviral, and antifungal activities, helping to protect the body from various pathogens by binding to them directly or depriving them of essential nutrients like iron.

Lactoferrin has the ability to reduce inflammation, potentially mitigating the effects of various inflammatory conditions and contributing to overall health and well-being.

Lactoferrin helps combat oxidative stress by neutralizing free radicals, contributing to the prevention of cellular damage and aging.

Some studies indicate lactoferrin may exhibit anticancer properties, inhibiting tumor growth and inducing apoptosis (programmed cell death) in cancer cells.

Lactoferrin can contribute to skin health by exhibiting antimicrobial properties against acne-causing bacteria and reducing inflammation, leading to clearer skin.

There is emerging evidence that lactoferrin can play a role in managing blood sugar levels and improving insulin sensitivity, making it potentially useful for people with diabetes or at risk of metabolic syndrome.

Beyond bacteria and viruses, lactoferrin has shown effectiveness against certain fungi, providing an additional layer of protection against infections.

Lactoferrin is crucial in pregnancy, supporting the immune system and iron metabolism, which are essential for healthy fetal development.